Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(26 Publications)
Rabbit Recombinant Monoclonal VEGF Receptor 1 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Mouse, Human, Rat, Chinese hamster samples. Cited in 26 publications.
View Alternative Names
FLT, FRT, VEGFR1, FLT1, Vascular endothelial growth factor receptor 1, VEGFR-1, Fms-like tyrosine kinase 1, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular permeability factor receptor, FLT-1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (AB184784)
Immunohistochemical analysis of paraffin-embedded Human gastric carcinoma tissue labeling VEGF with ab32152, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Cytoplasmic staining on human gastric carcinoma. Counterstained with Hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32152).
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (AB184784)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human abdominal aortic aneurysm (AAA) wall tissue sections labeling VEGF Receptor 1 with ab32152 at 1/100 dilution.
Resected aortic tissues were immersed in 10% neutral buffered formalin for at least 24 h for immunohistochemical staining. Tissue sample was embedded in paraffin; 4 µm sections were cut and mounted onto MAS-coated slides. The sections were deparaffinized, dehydrated, and boiled in a pressure cooker in 0.01 M citric acid buffer (pH 6.0) for 20 min. The sections were washed with phosphate-buffered saline and incubated with 3% H2O2 in absolute methanol for 5 min to inhibit any endogenous peroxidase activity. Sections were preincubated with 3% normal goat serum for 20 min to minimize nonspecific binding to VEGF Receptor 1, and incubated with ab32152 at 4°C overnight in a moist chamber. The section was washed with phosphate-buffered saline and then incubated with the appropriate secondary antibody for 30 min at room temperature. Staining was visualized with Vector DAB, and tissue section was then counterstained with hematoxylin.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32152).
Image from Sano M et al. PLoS ONE. 2014 Mar 20; 9(3). Fig 2E. DOI 10.1371/journal.pone.0089830. Lymphangiogenesis and Angiogenesis in Abdominal Aortic Aneurysm. e89830.
- IP
Lab
Immunoprecipitation - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (AB184784)
VEGF Receptor 1 was immunoprecipitated from 0.35 mg mouse brain lysate 10μg with ab32152 at 1 : 30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab32152 1 : 1000 dilution (2 μg/ml). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1 : 1000 dilution.
Lane 1 : Mouse brain lysate 10μg.
Lane 2 : ab32152 IP in mouse brain lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab32152 in mouse brain lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab32152).
All lanes:
Immunoprecipitation - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
Predicted band size: 151 kDa
false
- WB
Lab
Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (AB184784)
This data was developed using ab32152, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000,000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) 1 : 5,000 dilution used as loading control.
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (<a href='/en-us/products/primary-antibodies/vegf-receptor-1-antibody-y103-ab32152'>ab32152</a>) at 1/1000 dilution
Lane 1:
HEK-293T (human embryonic kidney epithelial cell) cells transfected with an empty vector contain a His-tag whole cell lysate at 20 µg
Lane 2:
HEK-293T cells transfected with a human VEGF Receptor 1 expression vector containing a His-tag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 180 kDa
false
Exposure time: 1s
- WB
Lab
Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (AB184784)
Blocking buffer and concentration : 5% NFDM/TBST
Diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (ab184784)
All lanes:
Mouse brain lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>)
Predicted band size: 151 kDa
false
Exposure time: 8s
- WB
Lab
Western blot - Anti-VEGF Receptor 1 antibody [Y103] - Low endotoxin, Azide free (AB184784)
This data was developed using ab32152, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000,000 dilution.
All lanes:
Western blot - Anti-VEGF Receptor 1 antibody [Y103] (<a href='/en-us/products/primary-antibodies/vegf-receptor-1-antibody-y103-ab32152'>ab32152</a>) at 1/1000 dilution
Lane 1:
Mouse placenta tissue lysate at 20 µg
Lane 2:
Rat placenta tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 180 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-VEGF Receptor 1 antibody [Y103]
Reactivity data
Product details
ab184784 is the carrier-free version of ab32152.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
What does low endotoxin mean?
Our low endotoxin, azide-free formats have low endotoxin level (1 EU/mg, determined by the TAL assay) and are free from azide, to achieve consistent experimental results in functional assays.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FLT-1 mediates important cellular responses such as cell migration and proliferation. Although it often functions in conjunction with other receptors like VEGFR-2 FLT-1 has unique binding affinities that modulate the availability of VEGF for other receptors. FLT-1 proteins as part of complex signaling networks actively contribute to maintaining vascular homeostasis and regulating blood vessel permeability.
Pathways
FLT-1 is an important component in the VEGF signaling pathway and also part of the PlGF/VEGF pathway. The receptor serves as a decoy to regulate the amount of VEGF interaction with VEGFR-2 influencing endothelial cell function and vascular permeability. By sequestering VEGF FLT-1 helps maintain the balance in this angiogenic signaling network interacting with proteins like VEGF PlGF and the anti-VEGF agents that target these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (26)
Recent publications for all applications. Explore the full list and refine your search
PeerJ 12:e16744 PubMed38250717
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical, cosmetic and investigational dermatology 15:2523-2534 PubMed36447569
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:972 PubMed34335914
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 9:654 PubMed33987352
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:315 PubMed33717258
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 8:1167 PubMed33241016
2020
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 61:28 PubMed32539131
2020
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medic 2019:2651037 PubMed31320912
2019
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medic 2018:7943212 PubMed30581486
2018
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology letters 222:72-82 PubMed23845850
2013
Applications
Unspecified application
Species
Rat
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com